This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA was engaged by a leading global medical device company to provide global transfer pricing advisory. CRA has been instrumental in all parts of its transfer pricing analyses, including IP onshoring, planning, global documentation compliance, audit support, quarterly/year-end support as needed.
Our work during 2022 spanned from assisting start-up companies expanding abroad for the first time to advising large multinationals on multibillion-dollar...
In this issue of Insights: Transfer Pricing, we include recent articles on transfer pricing issues, an upcoming speaking engagement, and industry...
CRA is a proud sponsor of the event. Rebel Curd is a panelist during the session titled “Analyzing transfer pricing cases and controversy strategies.” Anna...
Blockchain-based projects can incorporate multiple jurisdictions and require complex governance design, with operational and tax implications. This webinar...
